IREGENE THERAPEUTICS
Who is IREGENE THERAPEUTICS?
We are a biotechnology company dedicated to developing novel, chemically-derived allogeneic cell therapies for treating degenerative diseases such as Parkinson's Disease, Retinal Degenerative Diseases, and Ischemic Stroke. Our lead pipeline candidate, NouvNeu001, is set to initiate Phase I clinical ...See more
Industry & Specialities
Others
Countries of Operation
China Singapore
Headquarters:
China
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2017 (9 years)
Address:
9 GAOKEYUAN 3RD RD, EAST LAKE HIGH-TECH DEVELOPMENT ZONE; WUHAN, HUBEI, CN
Employees by Department
Key Decision Makers
Emmanuel Montet
Executive Vice President Corporate Development & Strategy
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
0employees
Senior
0employees
Non-managers
0employees
Financials
HIGH
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has IREGENE THERAPEUTICS been operating for?
- What is the funding status of IREGENE THERAPEUTICS?
- Where is IREGENE THERAPEUTICS's headquarter?
- What IREGENE THERAPEUTICS's spending power?
- Does IREGENE THERAPEUTICS have a presence in the domain it operates in?